The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial

The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial
Enrolling By Invitation
99 years or below
All
Phase N/A
90 participants needed
1 Location

Brief description of study

DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 24-27 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) (C) compared with Non-synchronized nasal intermittent positive pressure ventilation (NS-NIPPV), will reduce the incidence of (O) extubation failure within (T) 5 days (120 hours) of extubation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pre-term infants
  • Age: 99 years or below
  • Gender: All

Male and Female, Pre-term babies

Updated on 01 Aug 2024. Study ID: 21-1174
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research